US Specialty Formulations Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 14
  • Latest Deal Type
  • Debt - PPP

US Specialty Formulations General Information


Manufacturer and operator of specialty compound pharmacy for sterile injectable pharmaceuticals. The company provides aseptic compounding of FDA-approved pharmaceuticals for humans and animals and aseptic processing and production for injectable clinical trial materials.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Other Industries
Drug Delivery
Other Healthcare
Primary Office
  • 116 Research Drive
  • Bethlehem, PA 18015
  • United States
+1 (610) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

US Specialty Formulations Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - PPP 15-Apr-2020 00000 Completed
1. Debt - General 19-Oct-2015 00000 00000 Completed Startup
To view US Specialty Formulations’s complete valuation and funding history, request access »

US Specialty Formulations Executive Team (2)

Name Title Board Seat Contact Info
Kyle Flanigan Ph.D Co-Founder & Chief Executive Officer
Garry Morefield Ph.D Co-Founder & Chief Operating Officer
To view US Specialty Formulations’s complete executive team members history, request access »

US Specialty Formulations Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial